for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

FACTBOX-Vaccines delivered under COVAX sharing scheme for poorer countries

 (Updates Bolivia, Botswana, Ethiopia, Guatemala, Guinea, Indonesia, Ivory Coast, Honduras,
Jamaica, Kenya, Libya, Malaysia, Mozambique, Panama, Philippines, Tajikistan, Togo, Tunisia,
Zambia)
    Sept 21 (Reuters) - The COVAX facility, backed by the World Health Organization and the
Global Alliance for Vaccines and Immunization (GAVI), has delivered over 286 million COVID-19
vaccine doses to 141 countries, GAVI data shows, but in September the organisations running the
facility had to cut their 2021 delivery target by nearly 30% to 1.425 billion doses.

    The following tables list countries that have received vaccines under the scheme, sorted
alphabetically:

    AFRICA & MIDDLE EAST
    COUNTRY       LATEST     DELIVERY DATE     VACCINE TYPE       POPULATION   TOTAL DELIVERED
                 DELIVERY                                                      
    Algeria       567,600      August 31          Sinovac         44 million       932,400
    Angola        586,170      August 24      Pfizer/BioNTech     33 million     1.4 million
     Benin        302,400       July 26             J&J           12 million       446,400
   Botswana       101,760    September 18   AstraZeneca/Oxford   2.5 million       260,460
 Burkina Faso     151,200      August 1             J&J           21 million       417,400
   Cameroon       303,050       July 21             J&J           27 million       694,250
  Cape Verde      24,000       March 12     AstraZeneca/Oxford     556,000         24,000
    Central       302,400       July 22             J&J          4.8 million       302,400
    African                                                                    
   Republic                                                                    
     Chad         100,620       June 23       Pfizer/BioNTech     16 million       100,620
    Comoros       12,000       April 12     AstraZeneca/Oxford     870,000         12,000
    Islands                                                                    
     Congo        302,400      August 27            J&J          5.5 million       302,400
  Democratic      250,320     September 6         Moderna         90 million     2.0 million
  Republic of                                                                  
     Congo                                                                     
   Djibouti       151,200       July 17             J&J            988,000         175,200
     Egypt        299,700      August 16    AstraZeneca/Oxford   102 million     2.9 million
   Eswatini       302,400       July 27             J&J          1.1 million       328,800
   Ethiopia       271,200    September 17   AstraZeneca/Oxford   115 million     4.6 million
    Gambia        38,400       August 22    AstraZeneca/Oxford   2.4 million       376,800
     Ghana        487,600    September 14   AstraZeneca/Oxford    31 million     3.0 million
    Guinea        206,400    September 17         Sinovac         13 million       531,360
 Guinea-Bissau    28,800       August 18    AstraZeneca/Oxford   2.0 million       360,000
     Iran       1.0 million     July 30     AstraZeneca/Oxford    84 million     2.5 million
     Iraq         500,000      August 14      Pfizer/BioNTech     40 million       836,000
  Ivory Coast     35,700     September 20   AstraZeneca/Oxford    26 million     2.1 million
    Jordan        146,400       June 3      AstraZeneca/Oxford    10 million       436,800
     Kenya        795,600    September 17     Pfizer/BioNTech     54 million     5.0 million
    Lebanon       33,600       March 24     AstraZeneca/Oxford   6.8 million       33,600
    Lesotho       302,400       July 23             J&J          2.1 million       374,400
    Liberia       96,000       August 20    AstraZeneca/Oxford   5.1 million       494,400
     Libya        117,600    September 15   AstraZeneca/Oxford   6.9 million       347,400
  Madagascar      302,750       July 27             J&J           28 million       552,750
    Malawi        115,200      August 20    AstraZeneca/Oxford    19 million     1.1 million
     Mali         79,200     September 11   AstraZeneca/Oxford    20 million       626,400
  Mauritania      302,400      August 1             J&J          4.6 million       403,100
    Morocco       302,400       July 25             J&J           37 million       302,400
  Mozambique      188,000    September 17   AstraZeneca/Oxford    31 million       874,400
    Namibia       43,000        May 24      AstraZeneca/Oxford   2.5 million       67,000
     Niger        100,800     September 2   AstraZeneca/Oxford    24 million       758,200
    Nigeria     4.0 million    August 2           Moderna        206 million     7.9 million
  Palestinian     500,000      August 24          Moderna        4.7 million       664,400
  Territories                                                                  
    Rwanda        489,060      August 18      Pfizer/BioNTech     13 million     1.1 million
 Sao Tome and     24,000        March 3     AstraZeneca/Oxford     219,000         24,000
   Principe                                                                    
    Senegal       405,600    September 10   AstraZeneca/Oxford    17 million     1.4 million
  Seychelles      35,100      September 8     Pfizer/BioNTech       98,460         35,100
 Sierra Leone     113,490    September 13   AstraZeneca/Oxford   8.0 million       305,490
    Somalia       302,400      August 12            J&J           16 million       710,400
 South Africa   5.6 million     July 31       Pfizer/BioNTech     59 million     5.6 million
  South Sudan     152,950    September 15           J&J           11 million       344,450
     Sudan        218,400      August 27    AstraZeneca/Oxford    44 million     1.6 million
     Syria        256,800      April 22     AstraZeneca/Oxford    17 million       256,800
   Tanzania     1.0 million     July 24             J&J           60 million     1.0 million
     Togo         101,760    September 16   AstraZeneca/Oxford   8.3 million       613,420
    Tunisia       187,960    September 13     Pfizer/BioNTech     12 million     2.9 million
    Uganda        647,070     September 6         Moderna         46 million     2.1 million
     Yemen        151,200      August 30            J&J           30 million       511,200
    Zambia        124,500      August 17    AstraZeneca/Oxford    18 million     1.0 million
 
    EUROPE
  COUNTRY      LATEST      DELIVERY       VACCINE TYPE     POPULATION      TOTAL
              DELIVERY       DATE                                        DELIVERED
  Albania      40,800       June 2     AstraZeneca/Oxford  2.8 million    120,000
  Armenia      187,200    September 5  AstraZeneca/Oxford  3.0 million    261,200
 Azerbaijan    84,000       April 4    AstraZeneca/Oxford  10 million      84,000
                                                                        
   Bosnia      32,760       May 10      Pfizer/BioNTech    3.3 million     82,560
  Georgia      43,200      March 13    AstraZeneca/Oxford  3.7 million     43,200
   Kosovo      503,100    September 6   Pfizer/BioNTech    1.8 million    701,220
  Moldova      301,000     August 1           J&J          2.6 million    644,000
 Montenegro    24,000      March 28    AstraZeneca/Oxford    622,000       24,000
   North       38,400       May 14     AstraZeneca/Oxford  2.1 million     62,400
 Macedonia                                                              
   Serbia      115,200     August 25   AstraZeneca/Oxford  6.9 million    292,800
  Ukraine      188,000     August 29    Pfizer/BioNTech    44 million   3.5 million
 
    ASIA & PACIFIC
   COUNTRY        LATEST        DELIVERY        VACCINE TYPE      POPULATION       TOTAL
                 DELIVERY         DATE                                           DELIVERED
 Afghanistan      144,000       August 8     AstraZeneca/Oxford   39 million    4.2 million
  Bangladesh      781,440      August 21     AstraZeneca/Oxford   165 million  11.5 million
   Brunei         24,000        April 2      AstraZeneca/Oxford     437,000       24,000
   Cambodia       609,600       August 2            J&J           17 million    1.4 million
  East Timor      168,000      August 13     AstraZeneca/Oxford   1.3 million     292,800
     Fiji         56,000       August 24     AstraZeneca/Oxford     896,000       252,080
  Indonesia     3.6 million   September 17    Pfizer/BioNTech     274 million  23.1 million
   Kiribati       56,000       August 21     AstraZeneca/Oxford     119,000       104,000
  Kyrgyzstan      226,500       July 31      AstraZeneca/Oxford   6.6 million     226,500
     Laos         616,820       August 5     AstraZeneca/Oxford   7.3 million   1.8 million
   Malaysia       559,200     September 17   AstraZeneca/Oxford   32 million    1.4 million
   Maldives       112,000      August 23     AstraZeneca/Oxford     541,000       252,700
   Mongolia       188,370     September 9     Pfizer/BioNTech     3.3 million     379,490
    Nauru          7,200        April 2      AstraZeneca/Oxford     10,830         7,200
    Nepal       1.6 million    August 23     AstraZeneca/Oxford   29 million    3.4 million
   Pakistan       320,580     September 13    Pfizer/BioNTech     221 million   9.4 million
  Papua New       302,400       August 6            J&J           8.9 million     580,400
    Guinea                                                                     
 Philippines    2.6 million   September 20    Pfizer/BioNTech     110 million  15.8 million
    Samoa         112,000      August 23     AstraZeneca/Oxford     198,410       136,000
   Solomon        56,000       August 29     AstraZeneca/Oxford     687,000       108,800
   Islands                                                                     
  Sri Lanka       100,000      August 28      Pfizer/BioNTech     22 million    3.2 million
  Tajikistan      115,000     September 20    Pfizer/BioNTech     9.5 million   1.9 million
    Tonga         36,800       August 25     AstraZeneca/Oxford     106,000       60,800
    Tuvalu         4,800        April 8      AstraZeneca/Oxford     11,800         4,800
  Uzbekistan    1.2 million   September 14    Pfizer/BioNTech     34 million    5.2 million
   Vanuatu        24,000         May 19      AstraZeneca/Oxford     307,000       24,000
   Vietnam      1.5 million   September 14   AstraZeneca/Oxford   97 million   11.7 million
 
    AMERICAS
     COUNTRY        LATEST       DELIVERY        VACCINE TYPE        POPULATION       TOTAL
                   DELIVERY        DATE                                             DELIVERED
   Antigua and      16,800        June 9      AstraZeneca/Oxford       98,000         40,800
     Barbuda                                                                       
    Argentina       864,000      April 18     AstraZeneca/Oxford     45 million     1,082,000
     Bahamas        33,600       August 3     AstraZeneca/Oxford       393,000        67,200
    Barbados        33,600      August 24     AstraZeneca/Oxford       287,000       100,800
     Belize         33,600       August 3     AstraZeneca/Oxford       398,000       100,800
     Bermuda         9,600       April 6      AstraZeneca/Oxford       64,000         9,600
     Bolivia        19,200      August 19     AstraZeneca/Oxford     12 million    2.3 million
     Brazil         441,600      July 30      AstraZeneca/Oxford     213 million   8.9 million
      Chile         331,000       May 20      AstraZeneca/Oxford     19 million      489,400
    Colombia      2.1 million  September 13         Sinovac          51 million    6.4 million
   Costa Rica       86,400     September 5    AstraZeneca/Oxford     5.1 million     398,550
    Dominica        28,800       April 6      AstraZeneca/Oxford       72,000         28,800
    Dominican       184,800     August 27     AstraZeneca/Oxford     11 million      463,200
    Republic                                                                       
     Ecuador        101,760     August 16     AstraZeneca/Oxford     18 million      857,760
   El Salvador      188,370     August 27       Pfizer/BioNTech      6.5 million   3.6 million
     Grenada        21,600        May 26      AstraZeneca/Oxford       113,000        45,600
    Guatemala       307,200    September 16   AstraZeneca/Oxford     17 million    2.1 million
     Guyana         19,200      August 14     AstraZeneca/Oxford       787,000       120,000
      Haiti         500,000      July 14            Moderna          11 million      500,000
    Honduras        180,000    September 18   AstraZeneca/Oxford     9.9 million   3.8 million
     Jamaica        100,800    September 16   AstraZeneca/Oxford     3.0 million     326,400
     Mexico       2.2 million     May 27      AstraZeneca/Oxford     129 million   3.3 million
    Nicaragua       199,200    September 11   AstraZeneca/Oxford     6.6 million     468,600
     Panama         74,400     September 15   AstraZeneca/Oxford    4.3 million      148,800
    Paraguay        306,900    September 12   AstraZeneca/Oxford     7.1 million     865,140
      Peru          146,400    September 14   AstraZeneca/Oxford     33 million    2.2 million
 Saint Kitts and    21,600       April 7      AstraZeneca/Oxford       53,000         21,600
      Nevis                                                                        
   Saint Lucia      24,000     September 1    AstraZeneca/Oxford       184,000        74,400
  Saint Vincent     21,600        May 25      AstraZeneca/Oxford       111,000        45,600
     and the                                                                       
   Grenadines                                                                      
    Suriname        26,400       August 9     AstraZeneca/Oxford       587,000        79,200
  Trinidad and      33,600      August 11     AstraZeneca/Oxford     1.4 million     101,200
     Tobago                                                                        
     Uruguay        50,400     September 1    AstraZeneca/Oxford     3.5 million     148,800
    Venezuela       693,600    September 6          Sinovac          28 million      693,600
 
    Sources: WHO, UNICEF, GAVI, releases from local authorities

    
 (Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou in
Gdansk; editing by Milla Nissi, William Maclean and Giles Elgood)
  
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up